← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1998First marketed drug
Jun 1, 1995First NDA
Mar 14, 1997Last known activity
Aug 1, 2003
Acquired by Warner Lambert → Pfizer on Jan 1, 1999
Timeline
1980s
- Jan 1, 1984
Agouron— Founded
1990s
- Mar 14, 1997
nelfinavir— NDA Organization
- Jan 1, 1999
Warner Lambert— Acquired By
2000s
- Jan 1, 2000
Pfizer— Now
Drugs by trial phase (19 distinct, 20 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Approved for
Studied for
- Carcinoma, Non-Small-Cell Lung
- Central Nervous System Neoplasms
- Communicable Diseases
- Cytomegalovirus Retinitis
- Glioblastoma
- HIV Infections
- HIV Seropositivity
- Infections
- Lung Neoplasms
- Mycobacterium avium-intracellulare Infection
- Mycobacterium Infections
- Nervous System Neoplasms
- Opportunistic Infections
- Prostatic Neoplasms
- Retinitis
- Sarcoma
- Sarcoma, Kaposi
Marketed drugs (1)
Recent trials (20)
- NCT00205283CollaboratorN/AAug 1, 2003
- NCT00006441CollaboratorN/AFeb 1, 2003
- NCT00006326Lead sponsorN/AAug 1, 2000
- NCT00005001Lead sponsorPhase 2Mar 21, 2000
- NCT00005002Lead sponsorPhase 3Mar 21, 2000
- NCT00006211Lead sponsorPhase 2Feb 1, 2000
- NCT00004985Lead sponsorPhase 2Jan 1, 2000
- NCT00005000Lead sponsorPhase 4Dec 1, 1999
- NCT00002171Lead sponsorPhase 2Nov 2, 1999
- NCT00002164Lead sponsorPhase 1Nov 2, 1999
- NCT00002170Lead sponsorPhase 2Nov 2, 1999
- NCT00002235CollaboratorPhase 2Nov 2, 1999
- NCT00002185Lead sponsorPhase 2Nov 2, 1999
- NCT00002169Lead sponsorPhase 2Nov 2, 1999
- NCT00002165Lead sponsorN/ANov 2, 1999
Details
- Founded
- San Diego, CA, US Jan 1, 1984
- First NDA
- Mar 14, 1997
- Last known activity
- Aug 1, 2003
Designations held
- Priority review
- Accelerated approval